SEC Form 4 · accession 0001123292-19-000444
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D. Reed
Officer — Chief Science Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 9:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 4, 2019 | S | 16,500 | $4.24 | D | 62,840 | I | By trust |
| Common StockF3 | Mar 4, 2019 | S | 165,000 | $4.17 | D | 88,005 | I | By trust of spouse |
| Common StockF3 | Mar 4, 2019 | S | 44,000 | $4.22 | D | 44,005 | I | By trust of spouse |
| Common StockF3 | Mar 5, 2019 | S | 2,300 | $4.66 | D | 41,705 | I | By trust of spouse |
| Common Stock | holding | — | — | — | 96,280 | D | ||
| Common Stock | holding | — | — | — | 2,440 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale undertaken by reporting person's lender to whom the shares were pledged.
- F2Held by the Thomas David Reed Living Trust dated February 4, 2011.
- F3Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.